CATALOGO DEI PRODOTTI DELLA RICERCA

ZANOTTI, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.587
EU - Europa 2.920
AS - Asia 2.235
SA - Sud America 251
AF - Africa 23
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.035
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.549
GB - Regno Unito 1.061
CN - Cina 1.009
SG - Singapore 771
SE - Svezia 339
IT - Italia 256
DE - Germania 241
HK - Hong Kong 225
FR - Francia 224
BR - Brasile 207
IE - Irlanda 202
RU - Federazione Russa 198
FI - Finlandia 191
VN - Vietnam 63
UA - Ucraina 48
NL - Olanda 43
BE - Belgio 33
TR - Turchia 28
KR - Corea 25
CA - Canada 24
JP - Giappone 20
AT - Austria 18
IN - India 16
AR - Argentina 14
AU - Australia 13
BD - Bangladesh 13
ES - Italia 13
MX - Messico 11
UZ - Uzbekistan 10
ID - Indonesia 9
PL - Polonia 9
ZA - Sudafrica 7
CH - Svizzera 6
CL - Cile 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
IR - Iran 6
MA - Marocco 6
IQ - Iraq 5
LT - Lituania 5
PE - Perù 5
VE - Venezuela 5
CO - Colombia 4
GR - Grecia 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
PK - Pakistan 4
RO - Romania 4
AZ - Azerbaigian 3
BO - Bolivia 3
DK - Danimarca 3
LV - Lettonia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CG - Congo 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
LK - Sri Lanka 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
RS - Serbia 2
SI - Slovenia 2
TH - Thailandia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BG - Bulgaria 1
BJ - Benin 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
KH - Cambogia 1
ML - Mali 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
TG - Togo 1
TM - Turkmenistan 1
UY - Uruguay 1
Totale 9.035
Salva come PNG Salva come JPEG
Città #
Southend 928
Chandler 511
Singapore 365
Dallas 355
Jacksonville 320
Woodbridge 304
Ann Arbor 293
Beijing 247
Hong Kong 224
Ashburn 201
Dublin 200
Houston 155
Wilmington 106
New York 102
Jinan 88
Lawrence 80
Princeton 80
Nanjing 65
Munich 58
Shenyang 55
Helsinki 49
Verona 49
The Dalles 47
Bologna 39
Hebei 39
Los Angeles 39
Columbus 36
Tianjin 36
Ningbo 34
Brussels 33
Taizhou 29
Zhengzhou 29
Changsha 28
Haikou 28
Hangzhou 28
Boardman 25
Turku 24
Guangzhou 22
São Paulo 22
Groningen 21
Nanchang 21
Sindelfingen 21
Milan 19
Chicago 17
Jiaxing 17
Norwalk 17
Tokyo 17
Ho Chi Minh City 16
Manchester 16
Taiyuan 16
Dearborn 15
Redwood City 15
Seattle 15
Buffalo 14
Hanoi 14
Vienna 14
Falls Church 13
Santa Clara 13
Lancaster 12
Dong Ket 11
Seoul 11
Atlanta 10
Fuzhou 10
Lanzhou 10
Tashkent 10
Rome 9
San Francisco 9
Amsterdam 8
Brooklyn 8
Düsseldorf 8
Fairfield 8
Frankfurt am Main 8
Redmond 8
Stockholm 8
Washington 8
Denver 7
Mexico City 7
Toronto 7
Ardabil 6
Belo Horizonte 6
Boston 6
Chennai 6
Moscow 6
Nuremberg 6
Redondo Beach 6
Rio de Janeiro 6
Riva 6
Augusta 5
Clearwater 5
Council Bluffs 5
Jakarta 5
Kent 5
Lima 5
London 5
Montreal 5
Nova Iguaçu 5
Padova 5
San Mateo 5
Tappahannock 5
Warsaw 5
Totale 5.980
Salva come PNG Salva come JPEG
Nome #
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 258
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 181
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 180
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 172
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 172
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 168
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 167
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 158
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 155
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 155
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 155
BCR-signaling profiles associated with prognosis and progression in B-CLL 150
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 149
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 146
BCR-signaling profiles associated with prognosis and progression in B-CLL 146
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 146
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 145
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 139
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 132
Underdiagnosed systemic mastocytosis: The role of flow cytometry 132
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 132
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 132
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 126
Bone involvement in patient with clonal mast cell disorders 125
Bone involvement and osteoporosis in mastocytosis. 125
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 124
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 123
Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders 122
The high oxygen affinity haemoglobin Nantes: a family case description 122
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 121
Prevalence of osteoporosis in patients affected by mastocytosis 120
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 120
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 119
Osteopetrosi 117
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 117
Systemic mastocytosis: a muldisciplinary approach (Review) [Lamastocitosi sistemica: Un approccio multidiscliplinare] 116
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 115
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 113
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected 113
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms 112
Vaccination Management In Children and Adults With Mastocytosis 112
Effects of denosumab on peripheral lymphocyte subpopulations 112
Bone Disease in Mastocytosis 111
GREY ZONES OF HODGKIN LYMPHOMA: REPORT OF A CASE WITH FEATURES INTERMEDIATE BETWEEN PRIMARY MEDIASTINAL B-CELL LYMPHOMA, CLASSICAL HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA 108
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 105
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 104
Ultra-deep sequencing (UDS) allows more sensitive detection of the D816V and other KIT gene mutations in systemic mastocytosis 103
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 102
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 101
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 100
Skeletal implications of isolated bone marrow mastocytosis (reply): Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis (reply) 99
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 99
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 97
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 96
Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission 95
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 94
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry 94
Single Cell Network Profiling (SCNP) assay reveals B Cell Receptor Signaling heterogeneity in the Context of ZAP-70 Expression in patients with Chronic Lymphocytic Leukemia (CLL) 91
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 88
Rapid skeletal turnover in radiographic mimic of osteopetrosis might be secondary to systemic mastocytosis [corrected] 87
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation 84
Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series 84
Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association 82
Mast Cell Disorders In Drug Hypersensitivity 82
Mastocytosis and insect venom allergy 81
Mastocytosis and allergic diseases 78
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia 78
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study 76
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification 76
Male osteoporosis and hymenoptera venom anaphylaxis [Osteoporosi maschile e anafilassi da imenotteri] 74
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 73
Serum levels of bone cytokines in indolent systemic mastocytosis associated with osteopenia or osteoporosis. 71
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM 69
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders 69
Systemic Mastocytosis 66
Hymenoptera Allergy and Mast Cell Activation Syndromes 63
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives 55
Occupational exposure to glyphosate and risk of lymphoma:results of an Italian multicenter case-control study 49
null 44
Letter to the Editor: Rapid Skeletal Turnover in a Radiographic Mimic of Osteopetrosis Might Be Secondary to Systemic Mastocytosis 41
Night shift work and lymphoma: results from an Italian multicentre case-control study 41
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 31
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis 25
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis 13
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 11
Totale 9.134
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.872
article - articoli 22.256
book - libri 0
conference - conferenze 9.616
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.744
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021546 0 0 37 79 78 79 14 30 26 10 156 37
2021/2022744 55 237 8 91 42 19 21 42 35 22 39 133
2022/20231.442 92 170 114 292 92 362 30 76 163 10 26 15
2023/2024773 57 66 47 69 88 132 37 71 5 39 123 39
2024/20251.771 85 126 98 300 80 47 78 62 287 124 160 324
2025/2026964 379 301 284 0 0 0 0 0 0 0 0 0
Totale 9.134